This week in the BMJ

Volume 332, Number 7556, Issue of 24 Jun 2006

[Down]Treating carpal tunnel syndrome endoscopically may not be cost effective
[Down]Perioperative beta blockade may not benefit patients with diabetes
[Down]Adding metformin doesn't increase number of ovulations in women with PCOS
[Down]Sure Start local programmes may have limited effects
[Down]Screening for trypanosomiasis in Angola

Treating carpal tunnel syndrome endoscopically may not be cost effective

In the treatment of employed patients with carpal tunnel syndrome, endoscopic surgery is associated with modestly less pain than open surgery up to three months after operation, but it does not get patients back to work any faster. Atroshi and colleagues (p 1473) randomised 128 employed patients aged 25-60 years with idiopathic carpal tunnel syndrome to either endoscopic or open carpal tunnel release surgery. Both methods were equally effective in relieving symptoms. The small benefit makes the cost effectiveness of endoscopic surgery uncertain, say the authors.


Figure 1
Credit: PHOTOS.COM

 



[To top]


Perioperative beta blockade may not benefit patients with diabetes

Perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery may not significantly affect long term mortality and cardiac morbidity. The DIPOM Trial Group (p 1482) randomised 921 diabetic patients aged > 39 years and scheduled for major non-cardiac surgery to either 100 mg metoprolol or placebo, given from the day before surgery and continued for up to eight days. During a median follow-up of 18 months, all cause mortality, acute myocardial infarction, unstable angina, or congestive heart failure occurred in 21% of the metoprolol group and 20% of the placebo group. Confidence intervals, however, were wide, and the issue needs reassessment, conclude the authors.



[To top]


Adding metformin doesn't increase number of ovulations in women with PCOS

Metformin does not increase the number of ovulations or pregnancies when added to clomifene citrate as first line treatment in infertile women with polycystic ovary syndrome (PCOS). Moll and colleagues (p 1485) allocated 228 such women to clomifene citrate plus metformin or clomifene citrate plus placebo. The ovulation rate in the metformin group was 64% and 72% in the placebo group. Rates of ongoing pregnancy or spontanteous abortion showed no significant differences, and a significantly larger proportion of women in the metformin group stopped treatment because of side effects.


Figure 1
Credit: NAJEEB LAYYOUS/SPL

 



[To top]


Sure Start local programmes may have limited effects

The UK government's Sure Start local programmes to improve the health and development of socially deprived children < 4 years and their families seem to have only limited effects, varying with degree of social deprivation. In a cross sectional study, Belsky and collegues (p 1476), interviewed mothers and cognitively assessed children from English socially deprived communities with and without Sure Start programmes. The programmes benefited less socially deprived parents and their children, but they seemed to have an adverse effect on the most disadvantaged children.


Figure 1
Credit: LUCINDA MARLAND/ACAMY

 



[To top]


Screening for trypanosomiasis in Angola

Community screening for human African trypanosomiasis with a card agglutination test alone can lead to a substantial overdiagnosis. Inojosa and colleagues (p 1479) actively screened > 14 000 people using the agglutination test in northern Angola, an area with low prevalence of the disease. Of the 76 people who had a positive reaction in serum titration of 1:8 or more, only 10 had parasites detected in subsequent lymph node fluid or blood tests. Given the toxicity and cost of drugs used to treat trypanosomiasis, the card agglutination test should be used in conjunction with a second confirmatory test to guide treatment, say the authors.


Figure 1
Credit: A CRUMP/TOR/SPL

 



[To top]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ